Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells

Carcinogenesis

Volumn 30, Issue 1, 2009, Pages 28-34

  Chatagnon, Amandine ^a   Bougel, Stéphanie ^b   Perriaud, Laury ^a   Lachuer, Joël ^a   Benhattar, Jean ^b   Dante, Robert ^a,c  

^a INSERM   (France)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA METHYLATION; GENE REPRESSION; GENE SILENCING; GENETIC ASSOCIATION; HELA CELL; HUMAN; HUMAN CELL; LIVER CANCER; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; RNA INTERFERENCE; TRANSCRIPTION REGULATION;

CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; DNA-BINDING PROTEINS; HUMANS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERASE;

EID: 58949094559     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn240     Document Type: Article

References (32)

1. Ehrlich,M. (2002) DNA methylation in cancer: Too much, but also too little. Oncogene, 21, 5400-5413.
2. Esteller,M. (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet., 8, 286-298.
3. Herman,J.G. et al. (2003) Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med., 349, 2042-2054.
4. Kim,N.W. et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011-2015.
5. Stampfer,M.R. et al. (2003) Human epithelial cell immortalization as a step in carcinogenesis. Cancer Lett., 194, 199-208.
6. Yasumoto,S. et al. (1996) Telomerase activity in normal human epithelial cells. Oncogene, 13, 433-439.
7. Goueli,B.S. et al. (2003) Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor. Oncogene 22, 8042-8047.
8. Poole,J.C. et al. (2001) Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene, 269, 1-12.
9. Renaud,S. et al. (2005) CTCF binds the proximal exonic region of hTERT and inhibits its transcription. Nucleic Acids Res., 33 6850-6860.
10. Dessain,S.K. et al. (2000) Methylation of the human telomerase gene CpG island. Cancer Res., 60, 537-541.
11. Devereux,T.R. et al. (1999) DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. Cancer Res., 59, 6087-6090.
12. Guilleret,I. et al. (2002) Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity. Int. J. Cancer, 101, 335-341.
13. Nomoto,K. et al. (2002) Methylation status and expression of human telomerase reverse transcriptase mRNA in relation to hypermethylation of the p16 gene in colorectal cancers as analyzed by bisulfite PCR-SSCP. Jpn. J. Clin. Oncol., 32, 3-8.
14. Renaud,S. et al. (2007) Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene. Nucleic Acids Res., 35, 1245-1256.
15. Horikawa,I. et al. (1999) Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res., 59, 826-830.
16. Zinn,R.L. et al. (2007) hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res., 67, 194-201.
17. Guilleret,I. et al. (2004) Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines. Biochem. Biophys. Res. Commun., 325, 1037-1043.
18. Yi,X. et al. (2001) Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res., 29, 4818-4825.
19. Ducrest,A.L. et al. (2001) Regulation of human telomerase activity: Repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. Cancer Res., 61, 7594-7602.
20. Hendrich,B. et al. (1999) The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature, 401 301-304.
21. Bird,A.P. et al. (1999) Methylation-induced repression - belts, braces, and chromatin. Cell, 99, 451-454.
22. Fatemi,M. et al. (2006) MBD family proteins: Reading the epigenetic code. J. Cell Sci., 119, 3033-3037.
23. Klose,R.J. et al. (2005) DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol. Cell, 19, 667-678.
24. Ng,H.H. et al. (1999) MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat. Genet., 23, 58-61.
25. Wade,P.A. et al. (1999) Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat. Genet., 23, 62-66.
26. Auriol,E. et al. (2005) Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus. Nucleic Acids Res., 33, 4243-4254.
27. Billard,L.M. et al. (2002) MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland. Oncogene, 21, 2704-2712.
28. Lopez-Serra,L. et al. (2008) Unmasking of epigenetically silenced candidate tumor suppressor genes by removal of methyl-CpG-binding domain proteins. Oncogene, 27, 3556-3566.
29. Klose,R.J. et al. (2006) Genomic DNA methylation: The mark and its mediators. Trends Biochem. Sci., 31, 89-97.
30. Weber,M. et al. (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet., 39, 457-466.
31. Lopez-Serra,L. et al. (2006) A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer. Cancer Res., 66, 8342-8346.
32. Barr,H. et al. (2007) Mbd2 contributes to DNA methylation-directed repression of the Xist gene. Mol. Cell. Biol., 27, 3750-3757.